MEDTOX Scientific Inc. Sustainability Profile
MEDTOX Scientific Inc., headquartered in the United States, is a prominent player in the toxicology and diagnostic testing industry. Founded in 1986, the company has established itself as a leader in providing innovative solutions for drug testing and clinical diagnostics. With a strong presence across North America, MEDTOX is renowned for its comprehensive range of products, including urine drug testing kits and laboratory services, which are distinguished by their accuracy and reliability. The company has achieved significant milestones, including the development of advanced testing technologies that enhance the efficiency of toxicology screening. MEDTOX's commitment to quality and innovation has solidified its market position, making it a trusted partner for healthcare providers and laboratories. With a focus on improving patient outcomes, MEDTOX Scientific Inc. continues to set the standard in the field of diagnostic testing.
DitchCarbon Score
How does MEDTOX Scientific Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEDTOX Scientific Inc.'s score of 69 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MEDTOX Scientific Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Labcorp Holdings Inc., from which it inherits climate commitments and initiatives. As a current subsidiary of Labcorp Holdings Inc., MEDTOX Scientific Inc. aligns with the sustainability goals set by its parent company. Labcorp has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, which aim to reduce greenhouse gas emissions across its operations. While specific reduction targets for MEDTOX are not detailed, the overarching goals from Labcorp suggest a commitment to significant emissions reductions in the future. In summary, while MEDTOX Scientific Inc. does not provide its own emissions data or specific reduction targets, it is positioned within a framework of climate responsibility through its association with Labcorp Holdings Inc., which actively pursues sustainability and emissions reduction strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 69,115,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 178,899,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is MEDTOX Scientific Inc.'s Industry?
How Carbon Intensive is MEDTOX Scientific Inc.'s Location?
MEDTOX Scientific Inc.'s Scope 3 Categories Breakdown
MEDTOX Scientific Inc.'s Scope 3 emissions, which decreased by 4% last year and increased by approximately 10% since 2020, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 76% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 54% of Scope 3 emissions.
Top Scope 3 Categories
MEDTOX Scientific Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MEDTOX Scientific Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
